MLYS FY 2024 Earnings — Mineralys Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

MLYSMineralys Therapeutics, Inc.

$2B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$192M

Net Income

-$178M

EPS (Diluted)

$-3.66

Cash Flow

Operating Cash Flow

-$166M

Free Cash Flow

-$166M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$206M

Total Liabilities

$15M

Stockholders' Equity

$191M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$192M	-$85M	-127.3%
Net Income	-$178M	-$72M	-147.3%